Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 7, 1997, Pages 275-281

  Bacracheva, N ^a,d   Tyutyulkova, N ^b   Drenska, A ^b   Gorantcheva, J ^b   Schinzel, S ^c   Scholl, T ^c   Stoinov, A ^a   Tchakarski, I ^a   Tentcheva, J ^a   Vlahov, V ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Res Inst of Chem and Pharmaceut   (Bulgaria)

^c SANOFI   (France)

^d UNIVERSITY HOSPITAL 'QUEEN GIOVANNA'   (Bulgaria)

Author keywords

Cimetidine; Interaction; Metabolites pharmacokinetics; Metamizol

Indexed keywords

4 AMINOPHENAZONE; CIMETIDINE; DIPYRONE; DRUG METABOLITE; NORAMIDOPYRINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEMETHYLATION; DRUG ACETYLATION; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG OXIDATION; DUODENUM ULCER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; AREA UNDER CURVE; BIOTRANSFORMATION; CIMETIDINE; DIPYRONE; DRUG INTERACTIONS; DUODENAL ULCER; HISTAMINE H2 ANTAGONISTS; HUMANS;

EID: 0030743729     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Arellano F, Sacristan JA 1990 Metamizol: reassessment of its therapeutic role. Eur J Clin Pharmacol 38: 617-619
2. Aronson JK, Dengler HJ, Dettl L, Follath F 1988 Standardization of symbols in clinical pharmacology. Eur J Clin Pharmacol 35: 1-7
3. Bacracheva N, Drenska A, Gorantcheva J, Tyutyulkova N, Vlahov V 1995 Comparative bioavailability of two oral metamizol formulations: Influence of the acetylation phenotype. Arzneim-Forsch/Drug Res 45: 282-285
4. Bacracheva N, Vlahov V 1995 The acetylation phenotype: does it contribute to the non-linearity of the metabolite pharmacokinetics of metamizol? Eur J Clin Pharmacol 48: 79-80
5. Brockmeier D 1986 Model-free evaluation and mean-time concept in pharmacokinetics. Methods Find Exp Clin Pharmacol 8: 593-602
6. Christian CD, Meredith CG, Speeg KV 1984 Cimetidine inhibits renal procainamide clearance. Clin Pharmacol Ther 36: 221-227
7. Damm D 1989 Simultaneous determination of the main metabolites of dipyrone by high liquide chromatography. Arzneim-Forsch/Drug Res 39: 1415-1417
8. Desmond P, Pathwardhan R, Parker R, Schenker S, Speeg K 1980 Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci 26: 1261-1268
9. Feely J, Wilkinson G, Wood A 1981 Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 12: 692-695
10. Gerova Z, Vlahov V 1994 Phenotyping of debrisoquine hydroxylation in man. Anal Lab 3: 162-168
11. Grant D, Tang B, Kalow W 1984 A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 17: 459-464
12. Knodel R, Browne D, Gwozdz G, Brian W, Guengerich FP 1991 Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680-1691
13. Legemedelforbriket i Norge 1991-1995 Norsk Medisinaldepot AS, 1995, pp 61
14. Levy M, Zylber-Katz E, Granit L 1984 Plasma kinetics of dipyrone metabolites in rapid and slow acetylators. Eur J Clin Pharmacol 27: 453-458
15. Levy M, Zylber-Katz E, Rosenkranz B 1995 Clinical pharmacokinetics of metamizol and its metabolites. Clin Pharmacokinet 28: 216-234
16. Purunen J, Sotanieony E, Pelkonen O 1980 Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol 18: 185-187
17. Roberts R, Griece J, Wood L, Petroff V, McGuffie C 1981 Cimetidine impairs the elimination of of aminoantipyrine and theophylline. Gastroenterology 81: 19-23
18. Rohdewald P, Drehsen G, Milsmann E, Derendorf H 1983 Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy. Arzneim-Forsch/Drug Res 33: 985-988
19. Skrinska E, Tentcheva J 1987 Reversed phase liquide Chromatographic method for the detrmination of Biomet (cimetidine) in human plasma and urine. Abstracts, 31st International Congress of Pure and Applied Chemistry, July 13th-18th, Sofia 1987, Vol 2
20. Suomen Laaketilasto Finish Statistic on Medicines 1996 National Agency for Medicinas, Helsinki, pp. 38
21. Vlahov V, Badian M, Verho V, Bacracheva N 1990 Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. Eur J Clin Pharmacol 38: 61-65
22. Volz M, Kellner H-M 1980 Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br J Clin Pharmacol 10: 299-308
23. Weiss R, Brauer J, Goertz U, Petry R 1974 Vergleichende Untersuchung zur Frage der Absorption und Metabolisierung des Pyrazolonederivates Metamizol nach oraler Gabe bei Menschen. Arzeim-Forsch/Drug Res 24: 345-348
24. Zylber-Katz E, Caraco Y, Granit L, Levy M 1995. Dipyrone metabolism in liver disease. Clin Pharmacokin Ther 58: 198-209